| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |